Paradigm Immunotherapeutics to Present at LABEST 2022 Incubator Showcase

 Dr. Neil Bodie, CEO of Paradigm, will discuss Paradigm’s groundbreaking biological, virtual mask in his presentation, “A Breakthrough in SARS CoV-2/COVID Prophylactics.”

Dr. Neil Bodie, CEO of Paradigm Immunotherapeutics (“Paradigm”), will present at the Los Angeles Bioscience Ecosystem Summit (“LABEST 22”) on the Life Science tract on Thursday, May 26. Dr. Bodie’s panel will take place in the Exploration Room at the UCLA Meyer & Renee Luskin Conference Center.

Dr. Neil Bodie has more than twenty-five years of experience in biotech, with an expertise in immunopathology of infectious diseases and autoimmunity. He is the lead inventor of more than a dozen issued or pending U.S. and International patents (see https://patents.justia.com/inventor/neil-m-bodie).

During his presentation, entitled, “A Breakthrough in SARS-CoV-2/COVID Prophylactics,” Dr. Bodie will demonstrate the efficacy of Paradigm’s patent-pending biological, virtual mask designed to protect the immunocompromised population and, in the longer term HCWs, other high-risk groups and the general public, from the transmission of SARS CoV-2.

Paradigm’s ACE2 Fc fusion monoclonal antibodies are among the ultra-highest affinity mAbs against SARS CoV-2 in the world with low picomolar to low femtomolar binding affinity for Omicron BA.1/BA.2 respectively. Human lung organoid IC50 values are low to sub-nanomolar, making Paradigm’s ACE2 Fc fusion monoclonal antibodies among the most powerful anti-SARS CoV-2 mAbs in the world. By using the receptor to SARS CoV-2, ACE2 in Paradigm’s Fc fusion mAbs, Paradigm has developed one of the most SARS CoV-2 variant resistant mAbs and insuring that Paradigm’s mAbs don’t become obsolete even against future SARS CoV-2 Variants Of Concern (VOC).

LABEST 22 is the premier showcase for bioscience innovation in Los Angeles County produced by UCLA TDG (Technology Development Group), the tech transfer office for the University. This event is a collaboration with colleagues from across the county to present promising academic research, entrepreneurial faculty investigators, as well as local incubators and start-up companies.

Contact for Paradigm Immunotherapeutics:

Melissa Sheer

Kent Place Communications, LLC

melissa@kentplacellc.com

Kent Place Communications, LLC

Melissa Sheer

917-690-2199

www.kentplacecommunications.com

ContactContact

Categories

  • Business
  • Healthcare Management
  • Infectious Diseases
  • Medical & Health
  • Medical Research
  • Neurology
  • Trade Shows & Events

eCom Scotland Represented at This Year’s NHS Scotland Event

The digital learning and assessment specialist, eCom Scotland, is among the exhibitors accompanying Scotland’s leading event for healthcare professionals: The NHS Scotland Event 2021, which is being held, virtually, from 22nd to 24th June.

Scheduled to attract over 2,000 health and social care leaders, key decision makers and frontline staff from across NHS Scotland and its partners, the event offers an opportunity to listen, learn and participate in crucial dialogue about the future of health and care in Scotland. In particular, it provides a showcase for the best examples of health and social care services from the public, commercial, voluntary, academic and scientific communities.

Speakers at the event include the Cabinet Secretary for Health and Social Care, Humza Yousaf; the National Clinical Director, Jason Leitch, as well as the Minister for Mental Wellbeing and Social Care, Kevin Stewart. Wendy Edie, eCom Scotland’s Managing Director, commented, “In the past year, NHS Scotland and its partners across health and social care have risen impressively to the challenge of dealing with the coronavirus (COVID-19) pandemic.

“I’m sure Scotland’s healthcare professionals face significant challenges going forward – notably overcoming the health inequalities in Scotland highlighted by the pandemic. Nonetheless, taking up NHS Scotland’s mantra of ‘Re-mobilise, Recover and Re-design,’ there should now be opportunities to capitalise on the gains made in ways of working, prioritisation and collaboration, with the roll-out of new techniques, technology and clinically safe but faster pathways to care for patients.

“Now is the time to grasp change: communicate, innovate, lead and collaborate,” said Wendy. “That’s why eCom Scotland is keen be one of only a couple of dozen exhibitors at this event, which attracts delegates from the different health professions within NHS Boards, Health and Social Care Partnerships and the Third Sector, as well as those in senior management positions with control of budgets at local level.

“In particular, we’re keen to showcase a number of our eLearning programs which are in use within the healthcare sector,” Wendy added.

“Moreover, our customers in this sector – built up over the last 25 years – continue to tell us that these programs are highly cost-effective; they produce engaged and motivated learners; they contribute to continual performance improvement, and they provide excellent value-for-money for all stakeholders. With this level of support from these online learning materials, Scotland’s healthcare could be well placed to meet its current and future challenges efficiently and cost-effectively.”

eCom creates innovative learning solutions – aimed at increasing learning engagement and driving productivity – to help organisations achieve their goals. With offices in Dunfermline, Scotland, and Athens, Georgia, in the USA, but with customers from around the world, eCom focuses on the delivery, tracking and reporting of workforce learning and development through innovative technologies. Its products and services address a range of workforce management, development and training challenges, including eLearning, online assessment, blended learning, competency management and accreditation.